Inhibition of hypoxic pulmonary vasoconstriction by diphenyleneiodonium.
Thomas
H M
HM
Division of Pulmonary and Critical Care Medicine, Cornell University Medical College, Will Rogers Pulmonary Research Laboratory, White Plains, NY 10605.
Carson
R C
RC
Fried
E D
ED
Novitch
R S
RS
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D000860:Hypoxia / Q000503:physiopathology; D008168:Lung / Q000098:blood supply* / Q000187:drug effects / Q000502:physiology; D008297:Male; D008954:Models, Biological; D009247:NADH, NADPH Oxidoreductases / Q000037:antagonists & inhibitors; D019255:NADPH Oxidases; D009861:Onium Compounds / Q000494:pharmacology*; D010477:Perfusion; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D014661:Vasoconstriction / Q000187:drug effects*; D014665:Vasodilator Agents / Q000494:pharmacology*
D009861:Onium Compounds; D011450:Prostaglandin Endoperoxides, Synthetic; D014665:Vasodilator Agents; D000804:Angiotensin II; C007517:diphenyleneiodonium; D009247:NADH, NADPH Oxidoreductases; D019255:NADPH Oxidases